Dr Thomassen shares his personal experiences with the MFR2 IOL, including reasons why the MFR2 is his lens of preference, clinical findings from a real-life setting and considerations for future use.
Svein Erik Thomassen
Advertisement
Articles by Svein Erik Thomassen
Advertisement
Latest Updated Articles
- Real-world experience with the MFR2 IOL
Published: July 1st 2015 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved by FDA
2
Horizon Surgical Systems performs first AI-assisted cataract surgery
3
Quantifying intermittent retinal capillary perfusion in RVO and PDR
4
Q&A: Inder Paul Singh, MD, explores technician empowerment via the Academy Technician Training Platform
5
.png "Optometry Times"){kind=logo}
